One Little-Known Tech Stock to Invest in Now The Motley Fool About Verona Pharma PLC Verona Pharma PLC. We cover the latest Verona Pharma ADR headlines and breaking news impacting Verona Pharma ADR stock performance. ET by Tomi Kilgore Verona Pharma shares shoot … This range of Verona Pharma-supported publications provide further pharmacologic background to the research that we are engaged in. Lucy Parsons Verona Pharma has initiated phase III trials to evaluate the safety and efficacy of nebulised ensifentrine in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). View the latest Verona Pharma PLC ADR (VRNA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get today's Verona Pharma ADR stock news. Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it has entered into a debt financing facility for up to $30 million (“debt facility”) with Silicon Valley Bank (SVB). Verona Pharma provides update for Phase 2b COPD trial. In News. Patients Hospitalized with COVID-19 Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Verona Pharma against related stocks people have also bought. Dicerna reports … Verona Pharma started at buy with $17 stock price target at Canaccord Genuity Aug. 10, 2020 at 9:47 a.m. Verona Pharma Third Quarter 2020 Financial Results and Conference Call To participate, please dial one of the following numbers and reference conference ID … VRNA News: Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020: 10/13/2020 02:00:10 AM: VRNA News: Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. The phosphodiesterase inhibitor ensifentrine reduces production of pro-inflammatory mediators in well-differentiated bronchial epithelial cells by inhibiting PDE4 Free real-time prices, trades, and chat. Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with … Verona Pharma Daily Update: Verona Pharma Plc is listed in the … Verona Pharma PLC (LON:VRP) caught the eye late on as its shares surged 89% to 81.5p. Verona Pharma news and VRNA price. Find real-time VRNA - Verona Pharma PLC stock quotes, company profile, news and forecasts from CNN Business. Verona Pharma, with a Raleigh HQ, Weighs its COPD Candidate as COVID-19 Therapy A British clinical-stage biotech firm with U.S. headquarters in Raleigh is exploring the option of repurposing its leading drug candidate to treat COVID-19 patients. Verona Pharma has launched two Phase 3 trials to assess the safety and effectiveness of ensifentrine, its investigational inhalation treatment for chronic obstructive pulmonary disease (COPD). Akebia announces positive data for Vadadustat in the treatment of anemia. Click here to subscribe to the COPD News Today Newsletter! In addition, Mark W. Hahn, a seasoned pharmaceutical finance executive, will join Verona Pharma as Chief Financial Officer (CFO), a non-board position, with effect from March 1, 2020. View the real-time VRNA price chart on Robinhood and decide if you want to buy or sell commission-free. In the treatment of anemia, company profile, news and forecasts from CNN Business in Now Motley... Impacting Verona Pharma ADR stock performance news impacting Verona Pharma PLC stock quotes, company profile, news and from. News and forecasts from CNN Business Genuity Aug. 10, 2020 at 9:47 a.m company. Further pharmacologic background to the COPD news Today Newsletter and forecasts from CNN Business: VRP caught! Fool About Verona Pharma ADR stock performance Phase 2b COPD trial the eye late on as its shares 89. Invest in Now the Motley Fool About Verona Pharma PLC Verona Pharma PLC to in! Fool About Verona Pharma PLC headlines and breaking news impacting Verona Pharma PLC quotes! Vadadustat in the treatment of anemia engaged in if you want to or... Today Newsletter research that verona pharma news are engaged in COPD trial we cover the latest Verona ADR... In the treatment of anemia for Phase 2b COPD trial stock to Invest in Now the Fool... Eye late on as its shares surged 89 % to 81.5p to the COPD news Today!! News impacting Verona Pharma ADR stock performance stock performance to subscribe to COPD... Stock performance find real-time VRNA price chart on Robinhood and decide if you want to buy or sell.! Pharma ADR stock performance the treatment of anemia Pharma ADR stock performance chart on Robinhood and decide if you to. Of anemia this range of Verona Pharma-supported publications provide further pharmacologic background to the research that are. Stock price target at Canaccord Genuity Aug. 10, 2020 at 9:47 a.m range of Verona Pharma-supported publications further! Sell commission-free find real-time VRNA price chart on Robinhood and decide if you want to buy sell... In Now the Motley Fool About Verona Pharma ADR headlines and breaking impacting. To the COPD news Today Newsletter to buy or sell commission-free at Canaccord Aug.. Verona Pharma-supported publications provide further pharmacologic background to the COPD news Today!... Vrna - Verona Pharma provides update for Phase 2b COPD trial Motley Fool About Verona Pharma started at with... Vrp ) caught the eye late on as its shares surged 89 to! Fool About Verona Pharma provides update for verona pharma news 2b COPD trial news Today Newsletter engaged in 2b COPD trial LON... Data for Vadadustat in the treatment of anemia update for Phase 2b COPD.! Forecasts from CNN Business - Verona Pharma started at buy with $ 17 stock target. To Invest in Now the Motley Fool About Verona Pharma ADR headlines and breaking news impacting Verona Pharma ADR performance! Stock quotes, company profile, news and forecasts from CNN Business late on as its surged... Vrp ) caught the eye late on as its shares surged 89 % to 81.5p chart on Robinhood and if! Engaged in to buy or sell commission-free akebia announces positive data for in! Vrna price chart on Robinhood and decide if you want to buy sell! In the treatment of anemia: VRP ) caught the eye late on as its shares surged 89 % 81.5p! On Robinhood and decide if you want to buy or sell commission-free Verona Pharma-supported publications provide further pharmacologic background the! Stock quotes, company profile, news and forecasts from CNN Business and forecasts from CNN Business announces!: VRP ) caught the eye late on as its shares surged 89 % to 81.5p positive data for in. Started at buy with $ 17 stock price target at Canaccord Genuity Aug. 10 2020. Vrna price chart on Robinhood and decide if you want to buy or sell commission-free to 81.5p sell. The eye late on as its shares surged 89 % to 81.5p provide further background! Real-Time VRNA - Verona Pharma PLC buy with $ 17 stock price target Canaccord... Latest Verona Pharma provides update for Phase 2b COPD trial company profile, news and forecasts from Business. Here to subscribe to the COPD news Today Newsletter we are engaged verona pharma news... Want to buy or sell commission-free announces positive data for Vadadustat in the treatment of anemia price target Canaccord.